97332 ⎘
Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
ENGINEERED RECOMBINANT PROTEIN-BINDING DOMAINS AS DETECTION REAGENTS
#2ERYTHROCYTE-BINDING THERAPEUTICS
#3BACTERIAL COLICIN-IMMUNITY PROTEIN PROTEIN PURIFICATION SYSTEM
#4SCFV-FC DIMERS THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY
#5PROTEIN SCREENING AND DETECTION METHOD
#6PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES
#7COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS
#8ERYTHROCYTE-BINDING THERAPEUTICS
#9Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
#10BINDING PROTEINS RECOGNIZING HPV16 E7 ANTIGEN AND USES THEREOF
#11METHODS FOR PRODUCING PROTEINS
#12CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES
#13NOVEL METHODS FOR CREATING ALPHA-N-METHYLATED POLYPEPTIDES
#14scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity
#15Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#16METHOD FOR PREPARING GLY-TB4
#17N- and C-terminal tandem tag system for purification
#18VERSATILE DISPLAY SCAFFOLDS FOR PROTEINS
#19LINEAR POLYFUNCTIONAL MULTIMER BIOMOLECULE COUPLED TO POLYUBIQUITIN LINKER AND USE THEREOF
#20Erythrocyte-binding therapeutics
#21Tunable transcriptional regulators responsive to environmental triggers
#22Claudin-targeting agents and uses thereof
#23Erythrocyte-binding therapeutics
#24AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for infection
#25Methods, compositions, and uses of novel FYN kinase inhibitors
#26Bacterial colicin-immunity protein protein purification system
#27Method of making PDIA2 and compositions containing PDIA2
#28Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#29A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#30Synthetic multiphase systems
#31Mutant tumor necrosis factor receptor superfamily (TNFsfR) ligands and methods of making and using same
#32scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity
#33Versatile display scaffolds for proteins
#34Antigen-specific tolerance and compositions for induction of same
#35Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#36Neuroprotective agents derived from spider venom peptides
#37CONTROL SELF-CLEAVING PROTEIN ACTIVITY AND APPLICATION THEREOF
#38Hyperimmunized egg product for treatment of necrotic enteritis in poultry
#39Erythrocyte-binding therapeutics
#40Amino acid sequence presenting fusion polypeptide and its use
#41Protein screening and detection method
#42OmpA in vaccine compositions and as diagnostic targets
#43Botulinum neurotoxin and its derivatives
#44Bone delivery conjugates and method of using same to target proteins to bone
#45IN SITU AND IN VIVO ANALYSIS OF CHROMATIN INTERACTIONS BY BIOTINYLATED DCAS9 PROTEIN
#46Compositions comprising cupredoxins for treating cancer
#47Compositions and methods for inhibiting Wnt signaling
#48Design of pH-Sensitive Oligopeptide Complexes For Drug Release Under Mildly Acidic Conditions
#49Bacterial colicin-immunity protein protein purification system
#50AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infection
#51Strongyloides stercoralis protein and/or corresponding DNA and RNA sequences for application in diagnosis
#52Multispecific antibodies
#53Electrically conductive protein nanofibers and biofilms
#54Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#55Oligomers for TNF superfamily inhibition, methods of making and using
#56Heat-inducible self-assembling protein domains
#57Protein particles comprising disulfide crosslinkers and uses related thereto
#58Endoglin polypeptides and uses thereof
#59Enhanced hAT Family Transposon-Mediated Gene Transfer and Associated Compositions, Systems, and Methods
#60Hyperimmunized egg product for treatment of necrotic enteritis in poultry
#61ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and specificity
#62Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems and methods
#63Neuroprotective agents derived from spider venom peptides
#64Antigen-specific tolerance and compositions for induction of same
#65Compositions for generation of immune tolerance to specific antigens
#66Compositions for inducing antigen-specific tolerance
#67Libraries of modified fibronectin type III tenth domain-containing polypeptides
#68Off-axis collimation optics
#69Targeting GIV-GEF-GI signaling for treating diverse diseases
#70Erythrocyte-binding therapeutics
#71Hybrid protein for the identification of neddylated substrates
#72Live attenuated vaccines for pneumoviruses and related methods and materials
#73BMP peptides and methods of use
#74Modified Fab region-binding peptide
#75Recombinant deamidated gliadin antigen
#76Compositions comprising GRIM-19 therapeutics and methods of use
#77Systems for Factor VIII Processing and Methods Thereof
#78Method and means for purifying retroviral vectors
#79AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplasma phagocytophilum infection
#80Recombinant Deamidated Gliadin Antigen
#81Erythrocyte-binding therapeutics
#82Syndecan peptides and polypeptides and uses thereof
#83Peptides derived from NCAPG2 and their use
#84Mucin Derived Polypeptides
#85Methods for reducing immune responses
#86Compositions for inducing antigen-specific tolerance
#87Methods for induction of antigen-specific immune tolerance
#88Compositions for generating immune tolerance by targeting erythrocytes
#89Peptide inhibitors of TEAD/YAP-TAZ interaction
#90Methods of screening for Janus kinase 3 interacting compounds
#91Polypeptides comprising an ice-binding activity
#92Amino acid sequence presenting fusion polypeptide and its use
#93Antibody specifically binding to insulin-like growth factor-1
#94PCSK9 peptide combination vaccine and method of use
#95PTD-SMAD7 therapeutics
#96Method and compositions for treatment of calcineurin-related diseases
#97Protein particles comprising disulfide crosslinkers and uses
#98Oligomers for TNF superfamily inhibition
#99Gene from tidal flat metagenome and a novel protein displaying both phospholipase and lipase activities
#100Asparaginase and treating diseases associated with asparagine dependence
#101Endoglin polypeptides and uses thereof
#102Neuroprotective peptides that inhibit interaction between palmitoyl acyl transferase zinc-finger DHHC type containing 17 (zD17) and c-jun N-terminal kinase (JNK)
#103NOVEL FAR RED FLUORESCENT PROTEIN
#104Syndecan peptides and polypeptides as inhibitors of cancer
#105Syndecan peptides and polypeptides as inhibitors of cancer
#106Chromatography media and use thereof
#107Endoglucanase variants
#108BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
#109PCSK9 peptide combination vaccine and method of use
#110Peptide having affinity for silicon nitride (SiN), and use therefor
#111PCR reaction mixtures with decreased non-specific activity
#112Recombinant VapA and VapC peptides and uses thereof
#113Compositions and methods for treating multiple sclerosis
#114Detecting inclusion body myositis
#115Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#116Transmembrane protein as biosensors
#117Erythrocyte-binding therapeutics
#118PTD-SMAD7 therapeutics
#119ND2 peptides and methods of treating neurological disease
#120Luciferase biosensor
#121HSA-related compositions and methods of use
#122Asparaginase and treating diseases associated with asparagine dependence
#123Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#124Mutant luciferases
#125Inhibition of inflammation using antagonists of MUC1
#126Cell proliferation-promoting peptide and use thereof
#127Amino acid sequence presenting fusion polypeptide and its use
#128GPCR comprising an IC2 insertion
#129Antibody specifically binding to insulin-like growth factor-1
#130Quantitative standard for mass spectrometry of proteins
#131Protein complex system for increased immunogenicity and functionality, and methods making and use
#132Peptides that modulate complex SASPase-FLG2
#133BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
#134Method of producing bacteriophage preparations comprising purification using affinity chromatography
#135Recombinant deamidated gliadin antigen
#136Systems for factor VIII processing and methods thereof
#137EGFR-related polypeptides and methods of use
#138Expression and purification of fusion protein with multiple MBP tags
#139Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
#140Protease screening methods and proteases identified thereby
#141Telomerase activity inhibiting peptide and manufacturing method and application thereof
#142Compositions and methods for increasing serum half-life
#143HSA-related compositions and methods of use
#144NUCLEIC ACID CONSTRUCT, RECOMBINANT VECTOR, AND RECOMBINANT E. COLI PRODUCING CHICKEN ANEMIA VIRUS VP1 PROTEIN
#145Biological Agents Active in Central Nervous System
#146Targeting the neuromuscular junction for treatment
#147FGF BASED FIBRIN BINDING PEPTIDES
#148Protease screening methods and proteases identified thereby
#149PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY
#150Off-axis collimation optics
#151Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#152DDR2 PROTEIN WITH ACTIVATED KINASE ACTIVITY AND PREPARATION METHOD THEREOF
#153RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF
#154PCR reaction mixtures with decreased non-specific activity
#155GPCR comprising an IC2 insertion
#156Luciferase biosensor
#157Cell proliferation-promoting peptide and use thereof
#158Endoglucanase variants
#159Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
#160CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
#161Erythrocyte-binding therapeutics
#162Method of detection using antibodies that specifically bind hedgehog-derived polypeptides
#163Mutants of activation-induced cytidine deaminase (AID) and methods of use
#164COMPOSITIONS AND METHOD FOR DEIMMUNIZATION OF PROTEINS
#165Proteins
#166Methods and Compositions for Inhibiting Hepatitis C Virus Replication
#167Therapeutic approach to neurodegenerative disorders using a TFP5-peptide
#168VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS
#169Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof
#170THERAPEUTIC AND PROPHYLACTIC VACCINE FOR THE TREATMENT AND PREVENTION OF PAPILLOMAVIRUS INFECTION
#171Recombinant antigen for detection of toxocariasis
#172Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#173Erythrocyte-binding therapeutics
#174Mucin derived polypeptides
#175Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)
#176Cognate sampling kinetics
#177IMMUNOGENIC COMPOSITIONS COMPRISING HMGB1 POLYPEPTIDES
#178Fusion Protein Delivery System and Uses Thereof
#179Peptides for inhibiting the HPV-E6 oncoprotein
#180Megalin-based delivery of therapeutic compounds to the brain and other tissues
#181Recombinant toxin fragments
#182COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#183Inhibition of inflammation using antagonists of MUC1
#184Antibodies that specifically bind hedgehog-derived polypeptides
#185Polypeptides comprising an ice-binding activity
#186Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
#187Antibodies against delta-5 desaturase and uses thereof
#188Active surface coupled polymerases
#189Bone delivery conjugates and method of using same to target proteins to bone
#190Dynamic bio-nanoparticle elements
#191Bone delivery conjugates and method of using same to target proteins to bone
#192Cell-proliferation inhibiting VPg proteins, fragments or analogs thereof and their applications
#193REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES
#194COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#195Labeled fusion protein
#196Epitope-tag surface expressed proteins and nucleic acids thereof
#197Osteopenia animal model
#198RECOMBINANT ANTIGENS OF HUMAN CYTOMEGALOVIRUS (HCMV)
#199PATHOGEN BINDING
#200Receptor associated protein (RAP) conjugates
#201Recombinant toxin fragments
#202Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
#203RECOMBINANT DEAMIDATED GLIADIN ANTIGEN
#204SUMO fusion protein expression system for producing native proteins
#205Recombinant toxin fragments
#206METHOD FOR THE PRODUCTION OF HIGH-LEVEL SOLUBLE HUMAN RECOMBINANT INTERFERON ALPHA IN E. COLI AND VECTORS USEFUL FOR SUCH A PRODUCTION
#207Recombinant toxin fragments
#208Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
#209Mussel bioadhesive
#210Malaria Vaccines
#211Antibodies that specifically bind hedgehog-derived polypeptides
#212Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression
#213Recombinant toxin fragments
#214Protease screening methods and proteases identified thereby
#215Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells
#216PROTEIN, OSTEOCLAST DIFFERENTIATION INHIBITOR, INFLAMMATORY BONE RESORPTION THERAPEUTIC AGENT, GENE, RECOMBINANT VECTOR, METHOD OF MANUFACTURING A PROTEIN, METHOD OF INHIBITING OSTEOCLAST DIFFERENTIATION, AND METHOD OF TREATING INFLAMMATORY BONE RESORPTION
#217Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
#218METHOD FOR SEPARATING TARGET COMPONENT
#219Immunogenic Compositions Comprising Hmgb 1 Polypeptides
#220Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
#221Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity
#222Fusion protein delivery system and uses thereof
#223Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
#224Surface comprising DNA polymerase having mutations bound through an affinity tag
#225Methods and compositions comprising GFP
#226Nuclear transport nucleic acid delivery vector
#227Human pellino polypeptides
#228Recombinant toxin fragments
#229Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
#230Recombinant toxin fragments
#231Substrates and methods for assaying deubiquitinating enzymes
#232Pharmacokinetic modulation and compositions for modified FN3 polypeptides
#233Inhibitors of type 2 vascular endothelial growth factor receptors
#234Therapeutic molecules
#235Ddr2 protein with activated kinase activity and preparation method thereof
#236Sars coronavirus s proteins and uses thereof
#237Protein purification means
#238Method of producing target protein, fusion protein and gene thereof, protein consisting of partial sequence of intein and gene thereof, expression vector, and transformant
#239Structure and method for producing structure, toner containing structure, image forming method and device using toner
#240Structured construct and producing method therefor
#241Soluble recombinant protein production
#242Process for producing template DNA and process for producing protein in cell-free protein synthesis system with the use of the same
#243Antigenic fragment of human T-lymphotropic virus
#244Recombinant toxin fragments
#245MDA-7 and free radicals in the treatment of cancer
#246Multi-reporter gene model for toxicological screening
#247Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
#248Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity
#249Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
#250Bone delivery conjugates and method of using same to target proteins to bone
#251CARD-4 molecules and uses thereof
#252Method for producing by cell-free protein synthesis system using thioredoxin-fused protein expression vector
#253Recombinant toxin fragments
#254Rapid and enzymeless cloning of nucleic acid fragments
#255Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
#256Protein analysis
#257Luciferase biosensor
#258Catalytic efficiency and/or specificity of non-native substrates of enzymes
#259Novel method of diagnosing and treating gliomas
#260Human MEKK1 protein and nucleic acid molecules and uses therefor
#261Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
#262Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
#263Expression vector, host cell and method for producing fusion proteins
#264Neisseria mutants, lipooligosaccharides and immunogenic compositions
#265Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#266Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins
#267Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
#268Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
#269Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
#270Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
#271Fusion protein delivery system and uses thereof
#272Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
#273Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor